Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Kollins Insider Profile
4 Followers
John Kollins, CEO, Director at Mateon Therapeutics, holds 0.00 shares in Mateon Therapeutics (Ticker: MATN), holds ― shares in Satsuma Pharmaceuticals (Ticker: STSA), holds 4.16K shares in Paratek Pharmaceuticals (Ticker: PRTK). Most recently, John Kollins ― shares of Mateon Therapeutics on ― for an estimated value of ―.
John Kollins has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Kollins holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by John Kollins
John Kollins's Trading History
Mateon Therapeutics
―
CEO, Director
―
$0.00
Satsuma Pharmaceuticals
―
President and CEO, Director
―
―
Paratek Pharmaceuticals
Oct 30, 2014
SVP, Chief Business Officer
Uninformative Buy
89.79K
$25.80K
List of latest transactions for each holding click on a transaction to see John Kollins's performance on stock
You May Also Like
John Kollins insider profile FAQ
What is the percentage of profitable transactions made by John Kollins?
The percentage of profitable transactions made by John Kollins is ―.
What is the average return per transaction made by John Kollins?
The average return per transaction made by John Kollins is ―.
What stocks does John Kollins hold?
John Kollins holds: MATN, STSA, PRTK stocks.
What was John Kollins’s latest transaction?
John Kollins latest transaction was an Uninformative Buy of ―.
What was John Kollins's most profitable transaction?
John Kollins’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is John Kollins's role in Mateon Therapeutics?
John Kollins's role in Mateon Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.